Chondrocytes and synoviocytes were seeded in an 8 wells chamber slides at a density of 3 × 104/cm2 cells for 3 days in DMEM (SIGMA-ALDRICH) with 10% FCS. Successively, cells were treated with IL-1β (5 ng/mL, R&D) for 18 h, then the medium containing IL-1β was removed and substituted in half of the wells with fresh DMEM + 10% FBS (CTR) and in the other half with the same medium containing 10 μg/mL of sEV and cultured for 4 and 15 h. At the end of each experimental time point (4 h and 15 h) the cells were fixed with 4% PFA, treated for antigen unmasking with a solution of 0.02 U/mL of chondroitinase ABC in 50 mM TRIS–HCl pH 8 (for chondrocytes) or with a solution of 0.1% of Triton X-100/PBS (for synoviocytes) and blocked with 4% bovine serum albumin (BSA) (SIGMA-ALDRICH) in 0.1% Triton X-100/TBS (dilution buffer, used for primary and secondary antibodies dilution) to avoid unspecific bindings. Successively, cells were incubated with rabbit anti-human p65 (ABCAM AB7970, rabbit polyclonal antibody, 5 µg/ml) for 4 h at RT, followed by incubation with 15 μg/mL of donkey anti-rabbit IgG Alexa Fluor 555 (THERMOFISHER SCIENTIFIC). The nuclei were labeled with a DAPI solution (SIGMA-ALDRICH). Slides were mounted with the antifade reagent and examined under the NIKON A1-R confocal laser scanning microscope as described above.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.